StockData

BioHarvest Sciences vs Sunshine Biopharma

BHST and SBFM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BHST and SBFM compare

BioHarvest Sciences grew revenue faster over the last twelve months (37.0% versus −5.2% for Sunshine Biopharma).

Sunshine Biopharma keeps more of each dollar of sales as profit, with a net margin of −17.5% compared with −32.3% at BioHarvest Sciences.

Sunshine Biopharma scores higher on the StockData Score (12 against 5 for BioHarvest Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBHSTSBFM
Size and price
Market cap–$790K
Share price$1.63$2.84
Change, 1 year−76.3%−99.2%
Change, 5 years−84.9%−76.3%
Beta (5Y)0.88–
Employees–50
StockData Score
Total score512 (better)
Valuation score03 (better)
Growth score2 (better)1
Performance score13 (better)
Health score25 (better)
Dividend score00
Valuation
P/S–0.0×
P/B–0.0×
Fair value–$213.99
Margin of safety–98.7%
Growth
Revenue growth (TTM)37.0% (better)−5.2%
Revenue growth, 5Y average–248%
Profitability
Gross margin59.3% (better)30.4%
Operating margin−16.2% (better)−17.2%
Net margin−32.3%−17.5% (better)
FCF margin−27.8%–
Return on equity−83.2%−23.4% (better)
Return on invested capital−163%−33.3% (better)
Financial health
Debt / equity0.01 (better)0.00
Current ratio3.976.47 (better)
Altman Z-score–−1.80
Piotroski F-score5 (better)4
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions7.4%28.9%
Held by insiders0.00%24.5%
Short interest, % of float0.33%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.